| Dr Suzanne Marie Galloway, MD | |
|
1675 Leahy St Ste 201a, Muskegon, MI 49442-5542 | |
| (231) 672-6600 | |
| (231) 728-1719 |
| Full Name | Dr Suzanne Marie Galloway |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 1675 Leahy St Ste 201a, Muskegon, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033319181 | NPI | - | NPPES |
| 206147 | Other | IL | MEDICARE PTAN GROUP |
| 4301500903 | Other | MI | STATE LICENSE |
| F400274105 | Other | IL | MEDICARE PTAN INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036119867 (Illinois) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 4301500903 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Women's Health Services | 9133171358 | 7 |
News Archive
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
U.N. humanitarian agencies on Monday said areas of the Libyan capital, Tripoli, "urgently need humanitarian assistance, including medical treatment for injuries caused by the ongoing conflict in the North African country," the U.N. News Centre reports.
Fred's Inc., a leading provider of pharmacy services in the southeast and Cardinal Health, Inc., one of the nation's largest healthcare services companies, today announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products to all of Fred's more than 360 in-store pharmacies and EIRIS Health Services in the United States.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
› Verified 9 days ago
| Entity Name | Mercy Women's Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467476143 PECOS PAC ID: 9133171358 Enrollment ID: O20050216000453 |
News Archive
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
U.N. humanitarian agencies on Monday said areas of the Libyan capital, Tripoli, "urgently need humanitarian assistance, including medical treatment for injuries caused by the ongoing conflict in the North African country," the U.N. News Centre reports.
Fred's Inc., a leading provider of pharmacy services in the southeast and Cardinal Health, Inc., one of the nation's largest healthcare services companies, today announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products to all of Fred's more than 360 in-store pharmacies and EIRIS Health Services in the United States.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
› Verified 9 days ago
| Entity Name | Mercy Health Partners - Physician Specialist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922248772 PECOS PAC ID: 2163572991 Enrollment ID: O20090616000615 |
News Archive
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
U.N. humanitarian agencies on Monday said areas of the Libyan capital, Tripoli, "urgently need humanitarian assistance, including medical treatment for injuries caused by the ongoing conflict in the North African country," the U.N. News Centre reports.
Fred's Inc., a leading provider of pharmacy services in the southeast and Cardinal Health, Inc., one of the nation's largest healthcare services companies, today announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products to all of Fred's more than 360 in-store pharmacies and EIRIS Health Services in the United States.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suzanne Marie Galloway, MD 1675 Leahy St Ste 201a, Muskegon, MI 49442-5542 Ph: (231) 672-6600 | Dr Suzanne Marie Galloway, MD 1675 Leahy St Ste 201a, Muskegon, MI 49442-5542 Ph: (231) 672-6600 |
News Archive
The Research Foundation of SUNY, which supports the advancement of education, research and discovery at the State University of New York, today announced it signed a licensing agreement with Biosense Webster Inc. for the rights to an Upstate Medical University innovation that helps locate and treat life-threatening heart arrhythmias.
U.N. humanitarian agencies on Monday said areas of the Libyan capital, Tripoli, "urgently need humanitarian assistance, including medical treatment for injuries caused by the ongoing conflict in the North African country," the U.N. News Centre reports.
Fred's Inc., a leading provider of pharmacy services in the southeast and Cardinal Health, Inc., one of the nation's largest healthcare services companies, today announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products to all of Fred's more than 360 in-store pharmacies and EIRIS Health Services in the United States.
When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.
› Verified 9 days ago
Dr. Mark T Karnes, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1775 Wells Ave, Muskegon, MI 49442 Phone: 231-773-9048 Fax: 231-777-1218 | |
Katherine Mccormick, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 428, Muskegon, MI 49442 Phone: 231-672-3300 Fax: 231-672-3380 | |
Katherine E Betcher, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 201a, Muskegon, MI 49442 Phone: 231-672-6600 Fax: 231-728-4691 | |
Karissa Leah Tryska, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St, Suite 428, Muskegon, MI 49442 Phone: 231-672-3300 Fax: 231-672-3380 | |
Dr. Thomas Edward Mccurdy, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2201 S Getty St, Muskegon, MI 49444 Phone: 231-737-1802 Fax: 231-737-1808 | |
Dr. Michael L Baker, D.O Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2005 Addison St, Muskegon, MI 49441 Phone: 231-288-6383 |